Eric Puro: Beyond Beta-glucans in the Functional Mushroom Industry
About this episode
Eric Puro is the CEO of KÄÄPÄ Biotech, the leading functional mushroom company in Europe based out of Finland. He joins us again on the Mycopreneur Podcast to discuss the release of their new white paper titled "Beyond Beta Glucans: Why the Future of Functional Mushrooms Depends on Bioactive Standards" which was released yesterday. Their research posits that the functional mushroom industry must move beyond measuring 'Beta-glucans' and to measuring species-specific bioactive compounds for more more substantiative efficacy and truthful labeling in the multi-billion dollar functional mushroom industry.
We also discuss the growth of the global mushroom industry at large, Eric's unique and proven approach to executive leadership, business culture internationally, and more.
Please rate and review this episode wherever you're listening ( :
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Mycopreneur publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Mycopreneur
Lee Carroll: Ergothioneine in Support of Psychedelic Therapy
Mycopreneur
Adam Miezio: Psychedelics in the Epstein Files
Mycopreneur
Robert Gallery: Ibogaine For Athletes with Traumatic Brain Injuries
Mycopreneur
Melanie Tremblay: The Hidden Dangers of AI-Generated Mushroom Claims
Mycopreneur